Summary & Overview
CPT 23065: Superficial Soft Tissue Biopsy, Shoulder
CPT code 23065 denotes a superficial soft tissue biopsy of the shoulder, used to obtain a tissue specimen from a small subcutaneous or surface-level lesion for pathological examination. This procedure is clinically important because it establishes diagnoses such as infection, inflammatory disease, or cancer, guiding subsequent treatment decisions and care pathways. Nationally, accurate coding and documentation for this procedure affect clinical tracking, quality measurement, and claims adjudication across payers.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical context for the procedure, typical sites of service, and the common payer landscape. The publication outlines benchmarks and coverage considerations, summarizes relevant coding nuances for claims submissions, and highlights areas where policy updates or payer-specific rules commonly influence authorization and reimbursement workflows.
This overview is intended for clinicians, coding professionals, and revenue cycle staff seeking a clear reference for CPT code 23065, its clinical purpose, and the payer environment that typically governs coverage and processing of claims for superficial shoulder soft tissue biopsies.
Billing Code Overview
CPT code 23065 describes a superficial soft tissue biopsy of the shoulder performed to obtain a tissue specimen from a suspicious lesion located at or near the surface of the shoulder, such as a small subcutaneous lump. The procedure involves removal of tissue for pathological analysis to determine the presence of abnormal cells, including malignancy.
Service type: Diagnostic biopsy, superficial soft tissue
Typical site of service: Outpatient clinic, physician office, or ambulatory surgical center (shoulder surface or subcutaneous shoulder tissue)
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient presents to an outpatient orthopedic clinic with a small, palpable, superficial lump over the lateral aspect of the right shoulder that has slowly increased in size over several months and is intermittently tender. The orthopedic surgeon performs a focused history and physical, documents size, location, and overlying skin changes, and obtains informed consent for a superficial soft-tissue biopsy. The procedure is performed in an ambulatory surgery center or office-based procedure room under local anesthesia with sterile technique. A small elliptical skin incision or punch sample is used to remove the lesion and underlying superficial soft tissue; hemostasis is achieved and the specimen is labeled and submitted to pathology for histologic evaluation. Postprocedure instructions and wound care are provided, and pathology results are returned to the ordering clinician to determine further management (observation, excision, or oncologic referral). Typical clinical workflow includes pre-procedure consent and localization, administration of local anesthetic, tissue sampling, specimen handling and documentation, and postprocedural follow-up for results and wound check. Typical site of service: outpatient clinic, ambulatory surgery center, or physician office. Service type: superficial soft-tissue biopsy of the shoulder for diagnostic histopathology.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing only the physician interpretation or professional portion of a diagnostic service associated with the procedure |